I'd at least hold off awhile with this new fund. It's not clear how it is managed and ISTM you are comparing its performance with the wrong benchmark.
Fidelity's prospectuses are typically vague, but this one more than usual. This is a fund of funds, but the prospectus doesn't make clear who is responsible for the asset allocations or even say anything about how they're done. I'll contrast it with the prospectus for FMRHX, another Fidelity fund of actively managed funds.
Investment strategies.
FMRHX: "The Adviser, under normal market conditions, will use an active asset allocation strategy to increase or decrease asset class exposures relative to the neutral asset allocations [previously specified] by up to
10%..."
FGDFX: silent. The only info I could find was in the SAI, where it says that "The fund may not purchase the securities of any issuer if, as a result, more than 25% of the fund's total assets would be invested in the securities of companies whose principal business activities are in the same industry." This doesn't really help understand the allocation among the underlying funds.
Investment Risks. Similar verbiage for both funds: "The fund is subject to risks resulting from the Adviser's asset allocation decisions." What decisions? By whom?
That gets us to the managers who are supposedly responsible for the asset allocation. It looks like Fidelity just threw the same eight managers at all the disruptor funds. Completely opaque as to who is steering which ship.
Is the ship being steered at all, or is it on autopilot? I looked at the l
atest monthly holding filing. That's a legal document, so it has to tell you what the fund is holding directly. That's different from Fidelity's sheet listing the securities it holds indirectly via the underlying funds.
The number of shares of the underlying funds are very similar. Given that the fund with the lowest value has the highest number of shares and so on down, the figures suggest that Fidelity is simply shooting for an even allocation (20%/fund) and periodically rebalancing. No asset allocation management, at least so far. This is a reason to wait - to see whether the fund really is on autopilot, or if it will change once it has more AUM.
As to the underlying holdings... Aside from the finance fund which is off in its own world, there's significant overlap among the underlying funds. Disregarding MasterCard (MA) and Capital One (COF) (which are in the finance fund), all of the other holdings in the top
15 are held by 2-3 of the underlying funds. Not unexpected, but it does call into question how much diversification you're getting.
Which brings us to the classification of this fund. I suspect M* classified it as LC Blend because it has to put new funds somewhere, and Fidelity didn't give any indication of how it would do asset allocation.
The underlying technology fund is 75% LCG. Communications is 53% LCG. Automation is 46% LCG. Medicine is slightly more LC blend (33%) than LCG (26%), but when you add in its MCG (23%) and SCG (4%), it's still a majority growth fund. Only Finance isn't a growth fund. But it's not the value fund one might expect, with only 22% invested in value, less than the 30% it has in growth stocks.
The fund as a whole is 45% LCG. Remember this is with a fairly neutral mix (finance currently constitutes
19.6% of the portfolio). So it seems fair to consider this a LCG fund, and those are the funds one might compare this with. Alternatively, one might compare it with some LCG global funds. This fund is 70/30 domestic/foreign. About 40% of the funds I could find with roughly this mix are world large stock (per M*).